Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors

BCR-ABL1-negative myeloproliferative neoplasms are burdened by a reduced life expectancy mostly due to an increased risk of thrombo-hemorrhagic events, fibrotic progression/leukemic evolution, and infectious complications. In these clonal myeloid malignancies, JAK2V617F is the main driver mutation,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Daniele Cattaneo, Alessandra Iurlo
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/f0387f2811bc4960a7bb65e2a6fc62db
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires